niaoduqing particles on proteinuria in patients with chronic nephritis efficacy（niaoduqing颗粒对慢性肾炎患者蛋白尿疗效）.docVIP

Niaoduqing particles on proteinuria in patients with chronic nephritis Efficacy Keywords: Objective: To investigate Niaoduqing particles of primary chronic glomerulonephritis proteinuria effect. Methods: Our hospital from 2005 to 2010 with primary chronic glomerulonephritis (PCGN total of 58 cases of hospitalized patients would be randomized 58 patients divided into Group A: 29 cases, particles with a package Niaoduqing four times daily, B group: 29 cases, enalapril 10mg once daily, two groups were given aspirin 100mg orally, once daily, double dipyridamole 50mg orally four times daily, treatment for two months. OUTCOME MEASURES: ⑴ 24-hour urine protein (UP quantitative, ⑵ serum creatinine (Cr), blood urea nitrogen (BUN), serum albumin (Alb), glycerol three lipid (TG), low density lipoprotein (LDLC), cholesterol (CHO). Results: Compared with the group before and after treatment and after treatment Niaoduqing compared with the control group, 24-hour urine protein, serum creatinine, blood urea nitrogen plasma albumin levels were significantly different (p lt;0.05). Conclusions: Niaoduqing particles significantly reduced urinary protein in patients with chronic nephritis, increased serum albumin, and its efficacy is superior to enalapril in delaying chronic renal insufficiency Progress Niaoduqing particles are also significantly better than enalapril. I. Materials and Methods Select a primary chronic glomerulonephritis (PCGN were 58 cases of hospitalized patients are in line with “primary glomerular disease classification and diagnostic criteria and treatment symposium Minutes” (1992 Huangshan meeting diagnostic criteria for chronic nephritis, and confirmed by pathology. and the exclusion of secondary glomerulonephritis, in which 33 males, 25 females, aged 14-65 years old (38 + -12 years old). pathological conditions: mild mesangial proliferative 28 cases, focal hyperplasia in 24 cases, Ⅰ six cases of membranous nephropathy. inclusion criteria: 1:24 hour